Thermo Fisher Scientific launches the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer

Thermo Fisher Scientific recently launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer. This next-generation sequencing platform is automated and delivers results in as little as twenty-four hours. The fully validated system, designed for clinical laboratories, enables users to accomplish clinical research and diagnostic testing on a single instrument.

President, clinical next-generation sequencing and oncology at Thermo Fisher Scientific, Garret Hampton, stated: “Next-generation sequencing has become an essential tool to bring the promise of precision medicine therapies to patients. With the automated, easy-to-use Genexus Dx Integrated Sequencer, any hospital, including regional and community hospitals, can bring NGS in-house, giving clinicians access to timely, comprehensive genomic profiling results. With faster answers, the results can aid clinicians in their patient management decision making which may include therapeutic options.”